Pontem (PNTM) 10-Q 12 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 12, 2022
Document Information Line Items
Entity Registrant Name	PONTEM CORPORATION
Trading Symbol	PNTM
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001830392
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	E9
Entity File Number	001-39882
Entity Tax Identification Number	98-1562955
Entity Address, Address Line One	1140 Avenue of the Americas
Entity Address, Address Line Two	9th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	(212)
Local Phone Number	457-9077
Title of 12(b) Security	Class A ordinary shares included as part of the units
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		69,000,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		17,250,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 155,474	$ 266,889
Prepaid expenses	330,904	497,110
Total current assets	486,378	763,999
Investments held in Trust Account	691,056,309	690,076,023
Derivative assets - forward purchase agreement	19,920
Total Assets	691,562,607	690,840,022
Current liabilities:
Accounts payable	24,790	27,142
Accrued expenses	739,799	806,178
Working capital loan - related party	1,042,579	592,388
Total current liabilities	1,807,168	1,425,708
Deferred legal fees	3,829,485	2,787,460
Deferred underwriting commissions	24,150,000	24,150,000
Derivative liabilities	4,359,330	30,246,530
Total Liabilities	34,145,983	58,609,698
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 69,000,000 shares issued and outstanding, at $10.01 and $10.00 per share at June 30, 2022 and December 31, 2021, respectively	690,956,000	690,000,000
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Class A ordinary shares, $0.0001 par value; 750,000,000 shares authorized, no non-redeemable shares issued and outstanding as of June 30, 2022 and December 31, 2021
Class B ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 17,250,000 shares issued and outstanding at June 30, 2022 and December 31, 2021	1,725	1,725
Accumulated deficit	(33,541,101)	(57,771,401)
Total shareholders’ deficit	(33,539,376)	(57,769,676)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit	$ 691,562,607	$ 690,840,022

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	5,000,000	5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Shares subject to possible redemption, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Shares subject to possible redemption per share (in Dollars per share)	$ 10.01	$ 10
Shares subject to possible redemption, shares issued	69,000,000	69,000,000
Shares subject to possible redemption, shares outstanding	69,000,000	69,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	750,000,000	750,000,000
Ordinary shares, non-redeemable shares issued (in Dollars)
Ordinary shares, non-redeemable shares outstanding (in Dollars)
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	100,000,000	100,000,000
Ordinary shares, shares issued	17,250,000	17,250,000
Ordinary shares, shares outstanding	17,250,000	17,250,000

Unaudited Condensed Statements

Unaudited Condensed Statements of Operations - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021		Jun. 30, 2022	Jun. 30, 2021
General and administrative expenses	$ 1,189,470	$ 617,750		$ 2,110,939	$ 980,522
General and administrative expenses - related party	45,000	45,000		90,000	90,000
Loss from operations	(1,234,470)	(662,750)		(2,200,939)	(1,070,522)
Other income (expense)
Change in fair value of derivative warrant liabilities	6,706,670	(7,988,040)		25,485,340	12,888,630
Change in fair value of the forward purchase agreement	(312,710)	(486,840)		421,780	(65,140)
Change in fair value of working capital loans	484,666			499,834
Financing costs - derivative warrant liabilities					(1,784,824)
Investment income on Trust Account	914,678	25,042		980,285	52,564
Net income (loss)	$ 6,558,834	$ (9,112,588)		$ 25,186,300	$ 10,020,708
Class A Ordinary Shares
Other income (expense)
Weighted average shares outstanding, basic (in Shares)	69,000,000	69,000,000		69,000,000	63,662,983
Weighted average shares outstanding, diluted (in Shares)	69,000,000	69,000,000		69,000,000	63,662,983	[1]
Net income (loss) per share, Basic (in Dollars per share)	$ 0.08	$ (0.11)	[1]	$ 0.29	$ 0.12	[1]
Class B Ordinary Shares
Other income (expense)
Weighted average shares outstanding, basic (in Shares)	17,250,000	17,250,000		17,250,000	17,075,967
Weighted average shares outstanding, diluted (in Shares)	17,250,000	17,250,000		17,250,000	17,250,000	[1]
Net income (loss) per share, Basic (in Dollars per share)	$ 0.08	$ (0.11)	[1]	$ 0.29	$ 0.12	[1]
[1]As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company.

Unaudited Condensed Statement_2

Unaudited Condensed Statements of Operations (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	[1]
Class A Ordinary Shares
Weighted average shares outstanding,diluted (in Shares)	69,000,000	69,000,000	69,000,000	63,662,983
Net income (loss) per share, diluted	$ 0.08	$ (0.11)	$ 0.29	$ 0.12
Class B Ordinary Shares
Weighted average shares outstanding,diluted (in Shares)	17,250,000	17,250,000	17,250,000	17,250,000
Net income (loss) per share, diluted	$ 0.08	$ (0.11)	$ 0.29	$ 0.12
[1]As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company.

Unaudited Condensed Statement_3

Unaudited Condensed Statements of Changes in Shareholders’ Deficit - USD ($)	Class B Ordinary Shares	Accumulated Deficit	Additional Paid-in Capital	Total
Balance at Dec. 31, 2020	$ 1,725	$ (57,315)	$ 23,275	$ (32,315)
Balance (in Shares) at Dec. 31, 2020	17,250,000
Excess of cash received over fair value of the private placement warrants			948,000	948,000
Accretion of Class A ordinary shares subject to redemption amount		(67,478,312)	(971,275)	(68,449,587)
Net income (loss)		19,133,296		19,133,296
Balance at Mar. 31, 2021	$ 1,725	(48,402,331)		(48,400,606)
Balance (in Shares) at Mar. 31, 2021	17,250,000
Balance at Dec. 31, 2020	$ 1,725	(57,315)	23,275	(32,315)
Balance (in Shares) at Dec. 31, 2020	17,250,000
Net income (loss)				10,020,708
Balance at Jun. 30, 2021	$ 1,725	(57,514,919)		(57,513,194)
Balance (in Shares) at Jun. 30, 2021	17,250,000
Balance at Mar. 31, 2021	$ 1,725	(48,402,331)		(48,400,606)
Balance (in Shares) at Mar. 31, 2021	17,250,000
Net income (loss)		(9,112,588)		(9,112,588)
Balance at Jun. 30, 2021	$ 1,725	(57,514,919)		(57,513,194)
Balance (in Shares) at Jun. 30, 2021	17,250,000
Balance at Dec. 31, 2021	$ 1,725	(57,771,401)		(57,769,676)
Balance (in Shares) at Dec. 31, 2021	17,250,000
Net income (loss)		18,627,466		18,627,466
Balance at Mar. 31, 2022	$ 1,725	(39,143,935)		(39,142,210)
Balance (in Shares) at Mar. 31, 2022	17,250,000
Balance at Dec. 31, 2021	$ 1,725	(57,771,401)		(57,769,676)
Balance (in Shares) at Dec. 31, 2021	17,250,000
Net income (loss)				25,186,300
Balance at Jun. 30, 2022	$ 1,725	(33,541,101)		(33,539,376)
Balance (in Shares) at Jun. 30, 2022	17,250,000
Balance at Mar. 31, 2022	$ 1,725	(39,143,935)		(39,142,210)
Balance (in Shares) at Mar. 31, 2022	17,250,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption		(956,000)		(956,000)
Net income (loss)		6,558,834		6,558,834
Balance at Jun. 30, 2022	$ 1,725	$ (33,541,101)		$ (33,539,376)
Balance (in Shares) at Jun. 30, 2022	17,250,000

Unaudited Condensed Statement_4

Unaudited Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net income	$ 25,186,300	$ 10,020,708
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(25,485,340)	(12,888,630)
Change in fair value of the forward purchase agreement	(421,780)	65,140
Change in fair value of working capital loans	(499,834)
Financing costs - derivative warrant liabilities		1,784,824
Income from investments held in Trust Account	(980,285)	(52,564)
Changes in operating assets and liabilities:
Prepaid expenses	166,205	(568,480)
Accounts payable	(2,352)	22,035
Accrued expenses	(66,379)	50,962
Due to related party		9,699
Deferred legal fees	1,042,025	261,132
Net cash used in operating activities	(1,061,440)	(1,295,174)
Cash Flows from Investing Activities:
Cash deposited in Trust Account		(690,000,000)
Net cash used in investing activities		(690,000,000)
Cash Flows from Financing Activities:
Repayment of note payable to related party		(226,948)
Proceeds received from initial public offering, gross		690,000,000
Proceeds received from private placement		15,800,000
Offering costs paid		(14,297,917)
Proceeds from working capital loan to related party	950,025	149,975
Net cash provided by financing activities	950,025	691,425,110
Net change in cash	(111,415)	129,936
Cash - beginning of the period	266,889
Cash - end of the period	155,474	129,936
Supplemental disclosure of noncash investing and financing activities:
Remeasurement of Class A ordinary shares to redemption value	956,000
Offering costs included in accrued offering costs		34,000
Offering costs included in deferred legal fees		45,479
Deferred legal fees		269,214
Deferred underwriting commissions		$ 24,150,000

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2022
Description of Organization and Business Operations [Abstract]
Description of Organization and Business Operations	Note 1 - Description of Organization and Business Operations Pontem Corporation (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on October 15, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). As of June 30, 2022, the Company had not commenced any operations. All activity for the period from October 15, 2020 (inception) through June 30, 2022 relates to the Company’s formation, and since the closing of the initial public offering (the “Initial Public Offering”), the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on its investments held in the trust account (the “Trust Account”) from the proceeds of its Initial Public Offering. The Company’s sponsor is Pontem LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on January 12, 2021. On January 15, 2021, the Company consummated its Initial Public Offering of 69,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which includes 9,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $690.0 million, and incurring offering costs of approximately $38.9 million, of which approximately $24.2 million and approximately $213,000 was for deferred underwriting commissions and deferred legal fees (the “Deferred Legal Fees”), respectively (Notes 2 and 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 10,533,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor and HSM-Invest, a Switzerland simple partnership (“HSM-Invest”), generating gross proceeds of $15.8 million (Notes 5 and 7). Upon the closing of the Initial Public Offering and the Private Placement, $690.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a Trust Account with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount held in trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which were adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or January 15, 2023, (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Capital Resources As of June 30, 2022, the Company had approximately $155,000 in its operating bank account and working capital deficit of approximately $278,000, exclusive of the working capital note outstanding with a fair value of $1.0 million. Prior to the Initial Public Offering, the Company’s liquidity needs were satisfied through a contribution of $25,000 from Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 5), a loan of up to approximately $300,000 from the Sponsor pursuant to a Note (as defined in Note 5), of which approximately $227,000 was drawn prior to repayment. The Company repaid the Note in full on January 18, 2021. Subsequent to the Initial Public Offering, the Company’s liquidity needs have been satisfied with the proceeds of $2.0 million from the consummation of the Private Placement not held in the Trust Account, as well as the proceeds from working capital loans (the “Working Capital Loans”). In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors have the ability and intent to provide the Company Working Capital Loans. On April 30, 2021, the Company entered into a Working Capital Loan Agreement with the Sponsor and HSM-Invest, pursuant to which the Company could borrow up to $1.2 million from the Sponsor and HSM-Invest for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination (the “Working Capital Promissory Note”). All unpaid principal under the Working Capital Promissory Note will be due and payable in full on the effective date of the Business Combination. On September 30, 2021, the Company entered into an amended and restated working capital loan agreement (the “Amended and Restated Agreement”) with its Sponsor and HSM-Invest, which increased the amount it may borrow to be up to $4.0 million. See Note 5 for a description of the Agreement, the Amended and Restated Agreement and the underlying Working Capital Loans. As of June 30, 2022 and December 31, 2021, the principal amount of approximately $1.6 million and $600,000, respectively, was borrowed and outstanding under the Working Capital Loans. The Working Capital Loans are presented at fair value on the accompanying condensed balance sheets and were approximately $1.0 million at June 30, 2022 and approximately $592,000 at December 31, 2021. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Notwithstanding, the Company is scheduled to liquidate on January 15, 2023. The Company must sign a letter of intent to acquire or combine with a viable business acquisition candidate as a condition of extending the liquidation date. Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K March 25, 2022. Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on the account. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2022 and December 31, 2021. Due to Related Party Due to related party consist of amounts due from an entity affiliated with the Sponsor. As of June 30, 2022 and December 31, 2021, the Company had approximately $0 and $10,000, respectively, outstanding. It is recorded as accrued expense and presented on the unaudited condensed balance sheets. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in investment income on Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as assets, liabilities or as equity, is re-assessed at the end of each reporting period. The Company is committed to issue Forward Purchase Units (defined below), which are recognized as derivative assets or liabilities depending on the fair value in accordance with ASC 815. Accordingly, the Company recognizes Forward Purchase Agreement (defined below) instruments as assets or liabilities at fair value and adjusts the instruments to fair value at each reporting period. The assets or liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of the Units associated with the Forward Purchase Agreement (defined below) have been estimated utilizing a forward pricing model. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of Public Warrants issued in connection with the Initial Public Offering are measured based on the listed market price of such warrants. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. As a result, the fair value of the Private Placement Warrants are based on the observable listed prices for the Public Warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were included in temporary equity along with accretion of the Class A ordinary shares. The Company classified deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Working Capital Loan - Related Party The Company has elected the fair value option to account for its Working Capital Loan - related party with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of its Working Capital Loan - related party on the condensed statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 69,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjust the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Income (Loss) per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted-average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 33,533,333 shares of ordinary shares in the calculation of diluted income per ordinary share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each class of ordinary shares: Three Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income (loss)- basic and diluted $ 5,247,067 $ 1,311,767 $ (7,290,070 ) $ (1,822,518 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 69,000,000 17,250,000 Basic and diluted net income (loss) per ordinary share $ 0.08 $ 0.08 $ (0.11 ) $ (0.11 ) Six Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income - basic $ 20,149,040 $ 5,037,260 $ 7,901,368 $ 2,119,340 Allocation of net income - diluted $ 20,149,040 $ 5,037,260 $ 7,884,373 $ 2,136,335 Denominator: Basic weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,075,967 Effect of dilutive securities - - - 174,033 Diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,250,000 Basic net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12 Diluted net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12 (1) As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company. Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is considering the impact of this pronouncement on the financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 3 - Initial Public Offering On January 15, 2021, the Company consummated its Initial Public Offering of 69,000,000 Units, which includes 9,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $690.0 million, and incurring offering costs of approximately $38.9 million, of which approximately $24.2 million and approximately $213,000 was for deferred underwriting commissions and Deferred Legal Fees, respectively. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2022
Private Placement [Abstract]
Private Placement	Note 4 - Private Placement Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 10,533,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor and HSM-Invest, generating gross proceeds of $15.8 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor, HSM-Invest or their permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On October 19, 2020, the Company issued 14,375,000 Class B ordinary shares to the Sponsor (the “Founder Shares”) in exchange for the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company. Shares and the associated amounts have been retroactively restated to reflect the shares capitalizations on December 23, 2020, January 8, 2021 and January 15, 2021, resulting in an aggregate of 17,250,000 Class B ordinary shares outstanding. The holders of the Founder Shares agreed to surrender and cancel up to an aggregate of 2,250,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional Units was not exercised in full by the underwriters, so that the Founder Shares would represent approximately 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On January 15, 2021, the underwriters fully exercised the over-allotment option; thus, these 2,250,000 Founder Shares are no longer subject to forfeiture. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (i) three years after the completion of the initial Business Combination or (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least one year after the initial Business Combination, the Founder Shares will be released from the lockup. Related Party Loans On October 16, 2020, the Sponsor agreed to loan the Company up to $300,000 pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed approximately $181,000 through December 31, 2020, and approximately $227,000 prior to the Initial Public Offering under the Note. The Company repaid the Note in full on January 18, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates have the ability and intent to loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On April 30, 2021, the Company entered a Working Capital Loan Agreement (the “Agreement”) with the Sponsor and HSM-Invest, pursuant to which the Company may borrow up to $1.2 million from the Sponsor and HSM-Invest for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. On April 30, 2021, pursuant to the Agreement, the Company issued a promissory note (the “Working Capital Promissory Note”) for the principal amount of $600,000 to the Sponsor and HSM-Invest, respectively. On September 30, 2021, the Company entered into an amended and restated working capital loan agreement (the “Amended and Restated Agreement”) with its Sponsor and HSM-Invest, which increased the amount it may borrow to be up to $4.0 million. Pursuant to the Amended and Restated Agreement, the Company issued a promissory note (the “Amended and Restated Working Capital Promissory Note”) for the principal amount of $2.0 million to each of the Sponsor and HSM-Invest, respectively. The Amended and Restated Working Capital Promissory Note does not bear any interest. All unpaid principal under the Amended and Restated Working Capital Promissory Note will be due and payable in full on the effective date of the Business Combination (the “Maturity Date”). The Sponsor and HSM-Invest will have the option, at any time on or prior to the Maturity Date, to convert up to $1.5 million under the Amended and Restated Working Capital Promissory Note into warrants to purchase the Company’s Class A ordinary shares, par value $0.0001 per share, at a conversion price of $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants sold concurrently with the Company’s Initial Public Offering. In the three and six months ended June 30, 2022, the Company borrowed an additional $950,000 under the Working Capital Loans. As of June 30, 2022 and December 31, 2021, approximately $1.6 million and $600,000, respectively, in principal was drawn under the Working Capital Loans, presented at the estimated fair value of approximately $1.0 million, and $592,000, respectively, on the accompanying condensed balance sheets. Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on NYSE through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $10,000 per month for office space, utilities, secretarial and administrative support services provided to members of the management team. The Company incurred $30,000 in such fees included as general and administrative expenses to related party on the accompanying unaudited condensed statements of operations for the three months ended June 30, 2022 and 2021. The Company incurred $60,000 in such fees included as general and administrative expenses to related party on the accompanying unaudited condensed statements of operations for the six months ended June 30, 2022 and 2021. As of June 30, 2022 and December 31, 2021, there was no balance due. In addition, the Sponsor, officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account. Consulting Agreement On October 15, 2020, the Company entered into an agreement to obtain consulting services from an affiliate of its Chief Financial Officer, pursuant to which the Company agreed to pay such affiliate of its Chief Financial Officer $5,000 per month. Consulting expenses resulting from such agreement were included within general and administrative expenses to related party in the accompanying unaudited condensed statements of operations. During the three months ended June 30, 2022 and 2021, the Company incurred $15,000 in consulting expenses. During the six months ended June 30, 2022 and 2021, the Company incurred $30,000 in consulting expenses. As of June 30, 2022 and December 31, 2021, the Company has prepaid expenses of $5,000 in connection with such services on the accompanying unaudited condensed balance sheets. Forward Purchase Agreement On January 12, 2021, the Company entered into a forward purchase agreement with QVIDTVM Management LLC (the “Forward Purchase Agreement”) providing for the purchase of up to 15,000,000 forward purchase units (the “Forward Purchase Units”), with each Forward Purchase Unit consisting of one Class A ordinary share (the “Forward Purchase Shares”) and one-third of one redeemable warrant to purchase one Class A ordinary share at $11.50 per share (the “Forward Purchase Warrants”), at a purchase price of $10.00 per Forward Purchase Unit, in a Private Placement to occur concurrently with the closing of the initial Business Combination. The number of Forward Purchase Units to be purchased by QVIDTVM Management LLC will be subject to the sole discretion of Mr. Alici, who has investment control over the capital committed to such entity, but in no event will be less than 5,000,000 Forward Purchase Units. The obligations under the Forward Purchase Agreement do not depend on whether any Class A ordinary shares held by Public Shareholders are redeemed by the Company. The obligation to purchase the Forward Purchase Units is subject to customary closing conditions, including that the initial Business Combination must be consummated substantially concurrently with, and immediately following, the purchase of Forward Purchase Units. The Forward Purchase Shares and Forward Purchase Warrants will be issued only in connection with the closing of the initial Business Combination. The proceeds from the sale of forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post-transaction company. The Forward Purchase Agreement is accounted for as an asset or liability measured at fair value with changes in fair value reported each period in earnings.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 - Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registered such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Pursuant to the Forward Purchase Agreement, the Company agreed to use its reasonable best efforts (i) to file within 30 days after the closing of a Business Combination a registration statement with the SEC for a secondary offering of the Forward Purchase Shares and the Forward Purchase Warrants (and underlying Class A ordinary shares), (ii) to cause such registration statement to be declared effective promptly thereafter but in no event later than sixty (60) days after the initial filing, (iii) to maintain the effectiveness of such registration statement until the earliest of (A) the date on which the Sponsor or its assignees cease to hold the securities covered thereby and (B) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act and (iv) after such registration statement is declared effective, cause us to conduct firm commitment underwritten offerings, subject to certain limitations. In addition, the Forward Purchase Agreement provides that these holders will have certain “piggy-back” registration rights to include their securities in other registration statements filed by the Company. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of our final prospectus to purchase up to 9,000,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On January 15, 2021, the underwriters fully exercised the over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $13.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Unit, or approximately $24.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Deferred Legal Fees The Company engaged a legal counsel firm for legal advisory services, and the legal counsel agreed to defer their fees in excess of $350,000. The deferred fee will become payable in the event that the Company completes a Business Combination. As of June 30, 2022 and December 31, 2021, the Company has incurred approximately $3.8 million and $2.8 million in connection with such services, reflected as Deferred Legal Fees on the accompanying condensed balance sheets, respectively. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and the conflict in Ukraine and the surrounding region on the industry and has concluded that while it is reasonably possible that these risks and uncertainties could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	6 Months Ended
	Jun. 30, 2022
Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 7 - Derivative Warrant Liabilities As of June 30, 2022 and December 31, 2021, the Company had 23,000,000 Public Warrants and 10,533,333 Private Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60 th The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities, other than the forward purchase securities, for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted-average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.10 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30 trading-day period ending three trading days before the Company sends the notice of redemption to the warrant holders; ● if the closing price of the Class A ordinary shares for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; ● provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted-average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	6 Months Ended
	Jun. 30, 2022
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 8 - Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company is authorized to issue 750,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 69,000,000 Class A ordinary shares outstanding, all of which were subject to possible redemption. The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets as of June 30, 2022 and December 31, 2021 are reconciled in the following table: Gross proceeds from Initial Public Offering $ 690,000,000 Less: Proceeds allocated to public warrants (31,280,000 ) Class A ordinary shares issuance costs (37,169,587 ) Plus: Accretion of carrying value to redemption value 68,449,587 Class A ordinary shares subject to possible redemption, December 31, 2021 $ 690,000,000 Remeasurement of redemption value of Class A ordinary shares subject to possible redemption 956,000 Class A ordinary shares subject to possible redemption, June 30, 2022 $ 690,956,000

Shareholders_ Deficit

Shareholders’ Deficit	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Shareholders’ Deficit	Note 9 - Shareholders’ Deficit Preference Shares Class B Ordinary Shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of ordinary shares outstanding after such conversion, including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination, any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans and the Forward Purchase Shares and Forward Purchase Warrants; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10 - Fair Value Measurements The following table presents information about the Company’s financial assets and liabilities that are measured at fair value. There were no financial assets or liabilities measured at fair value as of June 30, 2022 and December 31, 2020. Fair Value Measured as of June 30, 2022 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account – money market funds $ 691,056,309 $ - $ - $ 691,056,309 Derivative assets – Forward Purchase Agreement $ - $ - $ 19,920 $ 19,920 Liabilities: Derivative liabilities: Derivative liabilities – Public Warrants $ 2,990,000 $ - $ - $ 2,990,000 Derivative liabilities – Private Placement Warrants $ - $ 1,369,330 $ - $ 1,369,330 Total derivative liabilities: $ 2,990,000 $ 1,369,330 $ 19,920 $ 4,359,330 Working Capital Loans – related party $ - $ - $ 1,042,579 $ 1,042,579 Fair Value Measured as of December 31, 2021 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account – money market funds $ 690,076,023 $ - $ - $ 690,076,023 Liabilities: Derivative liabilities: Derivative liabilities – Public Warrants $ 20,470,000 $ - $ - $ 20,470,000 Derivative liabilities – Private Placement Warrants $ - $ 9,374,670 $ - $ 9,374,670 Derivative liabilities – Forward Purchase Agreement $ - $ - $ 401,860 $ 401,860 Total derivative liabilities: $ 20,470,000 $ 9,374,670 $ 401,860 $ 30,246,530 Working Capital Loans – related party $ - $ - $ 592,388 $ 592,388 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers to/from Levels 1, 2, and 3 during the six months ended June 30, 2022. The estimated fair value of the Public Warrants transferred from an initial Level 3 measurement to a Level 1 fair value measurement as the Public Warrants were separately listed and traded in March 2021. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement in July 2021, as the Company determined the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants. Level 1 assets include investments in money market funds that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Level 3 Valuation Techniques Forward Purchase Agreement The fair value of the Units associated with the Forward Purchase Agreement have been estimated utilizing a forward pricing model with Level 3 inputs. The Company determined that the initial fair value of the Units (including shares and warrants) associated with the Forward Purchase Agreement as of January 15, 2021, was insignificant. Inherent in a forward pricing model are assumptions related to expected life and risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the Units associated with the Forward Purchase Agreement. The expected life of the Units associated with the Forward Purchase Agreement is assumed to be equivalent to their remaining contractual term. The following table provides quantitative information regarding Level 3 fair value measurements inputs for Forward Purchase Agreement as their measurement dates: As of As of Forward Purchase Agreement: Expected term 0.50 0.50 Risk-free interest rate 2.48 % 0.06 % The change in the fair value of the derivative assets and liabilities, measured utilizing Level 3 measurements for the period for the six months ended June 30, 2022, is summarized as follows: Derivative liabilities at December 31, 2021 - Level 3 measurement $ 401,860 Change in fair value of forward purchase agreement - Level 3 measurement (401,860 ) Derivative liabilities at June 30, 2022 - Level 3 measurement $ - Derivative assets at December 31, 2021 - Level 3 measurement $ - Change in fair value of forward purchase agreement - Level 3 measurement 19,920 Derivative assets at June 30, 2022 - Level 3 measurement $ 19,920 Working Capital Loan - Related Party The estimated fair value of the Working Capital Loan - Related Party was estimated utilizing a Black-Scholes model with Level 3 inputs. The following table provides quantitative information regarding the inputs for the fair value measurement of the Working Capital Loan - Related Party as of their measurement dates: Working capital loan As of As of Exercise price $ 1.50 $ 1.50 Volatility 44.50 % 68.20 % Expected term 0.50 0.50 Risk-free interest rate 2.48 % 0.19 % Probability of Business Combination 70.00 % 100.00 % The change in the fair value of the Working Capital Loan - Related Party, measured utilizing Level 3 measurements for the period for the six months ended June 30, 2022, is summarized as follows: Working capital loan – related party at December 31, 2021 - Level 3 measurement $ 592,388 Proceeds from working capital loan to related party 950,025 Change in fair value of working capital loan - Level 3 measurement (499,834 ) Working capital loan – related party at June 30, 2022 - Level 3 measurement $ 1,042,579

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 11 - Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the condensed financial statements were issued. Based upon this review, other than the above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K March 25, 2022.
Emerging growth company	Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on the account.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2022 and December 31, 2021.
Due to Related Party	Due to Related Party Due to related party consist of amounts due from an entity affiliated with the Sponsor. As of June 30, 2022 and December 31, 2021, the Company had approximately $0 and $10,000, respectively, outstanding. It is recorded as accrued expense and presented on the unaudited condensed balance sheets.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in investment income on Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative instruments	Derivative instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as assets, liabilities or as equity, is re-assessed at the end of each reporting period. The Company is committed to issue Forward Purchase Units (defined below), which are recognized as derivative assets or liabilities depending on the fair value in accordance with ASC 815. Accordingly, the Company recognizes Forward Purchase Agreement (defined below) instruments as assets or liabilities at fair value and adjusts the instruments to fair value at each reporting period. The assets or liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of the Units associated with the Forward Purchase Agreement (defined below) have been estimated utilizing a forward pricing model. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of Public Warrants issued in connection with the Initial Public Offering are measured based on the listed market price of such warrants. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. As a result, the fair value of the Private Placement Warrants are based on the observable listed prices for the Public Warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were included in temporary equity along with accretion of the Class A ordinary shares. The Company classified deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Working Capital Loan - Related Party	Working Capital Loan - Related Party The Company has elected the fair value option to account for its Working Capital Loan - related party with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of its Working Capital Loan - related party on the condensed statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 69,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjust the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) per Ordinary Shares	Net Income (Loss) per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted-average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 33,533,333 shares of ordinary shares in the calculation of diluted income per ordinary share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each class of ordinary shares: Three Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income (loss)- basic and diluted $ 5,247,067 $ 1,311,767 $ (7,290,070 ) $ (1,822,518 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 69,000,000 17,250,000 Basic and diluted net income (loss) per ordinary share $ 0.08 $ 0.08 $ (0.11 ) $ (0.11 ) Six Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income - basic $ 20,149,040 $ 5,037,260 $ 7,901,368 $ 2,119,340 Allocation of net income - diluted $ 20,149,040 $ 5,037,260 $ 7,884,373 $ 2,136,335 Denominator: Basic weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,075,967 Effect of dilutive securities - - - 174,033 Diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,250,000 Basic net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12 Diluted net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12 (1) As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is considering the impact of this pronouncement on the financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of reconciliation of the numerator and denominator	Three Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income (loss)- basic and diluted $ 5,247,067 $ 1,311,767 $ (7,290,070 ) $ (1,822,518 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 69,000,000 17,250,000 Basic and diluted net income (loss) per ordinary share $ 0.08 $ 0.08 $ (0.11 ) $ (0.11 ) Six Months Ended June 30, 2022 2021 (1) Class A Class B Class A Class B Numerator: Allocation of net income - basic $ 20,149,040 $ 5,037,260 $ 7,901,368 $ 2,119,340 Allocation of net income - diluted $ 20,149,040 $ 5,037,260 $ 7,884,373 $ 2,136,335 Denominator: Basic weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,075,967 Effect of dilutive securities - - - 174,033 Diluted weighted average ordinary shares outstanding 69,000,000 17,250,000 63,662,983 17,250,000 Basic net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12 Diluted net income per ordinary share $ 0.29 $ 0.29 $ 0.12 $ 0.12

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	6 Months Ended
	Jun. 30, 2022
Class A Ordinary Shares Subject To Possible Redemption [Abstract]
Schedule of balance sheet	Gross proceeds from Initial Public Offering $ 690,000,000 Less: Proceeds allocated to public warrants (31,280,000 ) Class A ordinary shares issuance costs (37,169,587 ) Plus: Accretion of carrying value to redemption value 68,449,587 Class A ordinary shares subject to possible redemption, December 31, 2021 $ 690,000,000 Remeasurement of redemption value of Class A ordinary shares subject to possible redemption 956,000 Class A ordinary shares subject to possible redemption, June 30, 2022 $ 690,956,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of financial assets or liabilities measured at fair value	Fair Value Measured as of June 30, 2022 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account – money market funds $ 691,056,309 $ - $ - $ 691,056,309 Derivative assets – Forward Purchase Agreement $ - $ - $ 19,920 $ 19,920 Liabilities: Derivative liabilities: Derivative liabilities – Public Warrants $ 2,990,000 $ - $ - $ 2,990,000 Derivative liabilities – Private Placement Warrants $ - $ 1,369,330 $ - $ 1,369,330 Total derivative liabilities: $ 2,990,000 $ 1,369,330 $ 19,920 $ 4,359,330 Working Capital Loans – related party $ - $ - $ 1,042,579 $ 1,042,579 Fair Value Measured as of December 31, 2021 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account – money market funds $ 690,076,023 $ - $ - $ 690,076,023 Liabilities: Derivative liabilities: Derivative liabilities – Public Warrants $ 20,470,000 $ - $ - $ 20,470,000 Derivative liabilities – Private Placement Warrants $ - $ 9,374,670 $ - $ 9,374,670 Derivative liabilities – Forward Purchase Agreement $ - $ - $ 401,860 $ 401,860 Total derivative liabilities: $ 20,470,000 $ 9,374,670 $ 401,860 $ 30,246,530 Working Capital Loans – related party $ - $ - $ 592,388 $ 592,388
Schedule of provides quantitative information Level 3 fair value	As of As of Forward Purchase Agreement: Expected term 0.50 0.50 Risk-free interest rate 2.48 % 0.06 %
Schedule of change in the fair value of the working capital loan	Derivative liabilities at December 31, 2021 - Level 3 measurement $ 401,860 Change in fair value of forward purchase agreement - Level 3 measurement (401,860 ) Derivative liabilities at June 30, 2022 - Level 3 measurement $ -
Schedule of change in the fair value of the derivative assets	Derivative assets at December 31, 2021 - Level 3 measurement $ - Change in fair value of forward purchase agreement - Level 3 measurement 19,920 Derivative assets at June 30, 2022 - Level 3 measurement $ 19,920
Schedule of fair value measurement of working capital loan	Working capital loan As of As of Exercise price $ 1.50 $ 1.50 Volatility 44.50 % 68.20 % Expected term 0.50 0.50 Risk-free interest rate 2.48 % 0.19 % Probability of Business Combination 70.00 % 100.00 %
Schedule of change in the fair value of the working capital loan	Working capital loan – related party at December 31, 2021 - Level 3 measurement $ 592,388 Proceeds from working capital loan to related party 950,025 Change in fair value of working capital loan - Level 3 measurement (499,834 ) Working capital loan – related party at June 30, 2022 - Level 3 measurement $ 1,042,579

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)			6 Months Ended
	Sep. 30, 2021	Jan. 15, 2021	Jun. 30, 2022	Dec. 31, 2021	Apr. 30, 2021
Description of Organization and Business Operations (Details) [Line Items]
Deferred underwriting commissions		$ 24,200,000
Deferred legal fees		213,000
Trust account price per share (in Dollars per share)			$ 10
Business combination tangible assets net			$ 5,000,001
Public shares aggregate percentage			15%
Obligation to redeem public shares percentage			100%
Dissolution expenses			$ 100,000
Outstanding public shares redemption percentage			100%
Trust account related dissolution expenses			$ 100,000
Trust account related, description			In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Operating bank account			$ 155,000
Working capital deficit			278,000,000,000
Fair value outstanding			1,000,000
Contribution from sponsor to cover expenses			25,000
Sponsor loan			300,000
Borrowing amount					$ 1,200,000
Borrowing expenses	$ 4,000,000
Principal amount under working capital			1,600,000	$ 600,000
Working capital loan			$ 1,000,000	$ 592,000
IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)			$ 10
Gross proceeds		$ 690,000,000
Net proceeds			$ 690,000,000
Sponsor loan outstanding			227,000
Proceeds from issuance initial public offering			$ 2,000,000
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)		$ 10
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Shares issued (in Shares)			10,533,333
Price per share (in Dollars per share)			$ 1.5
Gross proceeds			$ 15,800,000
Offering costs		$ 38,900,000
Class A Ordinary Shares [Member] | IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Shares issued (in Shares)		69,000,000
Class A Ordinary Shares [Member] | Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Shares issued (in Shares)		9,000,000
Business Combination [Member] | IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Aggregate fair market value			80%
Outstanding voting securities percentage			50%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies (Details) [Line Items]
Federal depository insurance coverage	$ 250,000
Due to related party	$ 0	$ 10,000
Aggregate shares purchased (in Shares)	33,533,333
Class A Ordinary Shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Shares subject to possible redemption (in Shares)	69,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the numerator and denominator - USD ($)		3 Months Ended			6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021		Jun. 30, 2022	Jun. 30, 2021
Class A [Member]
Numerator:
Allocation of net income (loss)- basic		$ 5,247,067	$ (7,290,070)	[1]	$ 20,149,040	$ 7,901,368	[1]
Allocation of net income - diluted		$ 5,247,067	$ (7,290,070)		$ 20,149,040	$ 7,884,373	[1]
Denominator:
Basic weighted average ordinary shares outstanding (in Shares)		69,000,000	69,000,000	[1]	69,000,000	63,662,983	[1]
Effect of dilutive securities	[1]
Diluted weighted average ordinary shares outstanding (in Shares)		69,000,000	69,000,000		69,000,000	63,662,983	[1]
Basic net income per ordinary share (in Dollars per share)		$ 0.08	$ (0.11)	[1]	$ 0.29	$ 0.12	[1]
Diluted net income per ordinary share (in Dollars per share)		$ 0.08	$ (0.11)		$ 0.29	$ 0.12	[1]
Class B [Member]
Numerator:
Allocation of net income (loss)- basic		$ 1,311,767	$ (1,822,518)	[1]	$ 5,037,260	$ 2,119,340	[1]
Allocation of net income - diluted		$ 1,311,767	$ (1,822,518)		$ 5,037,260	$ 2,136,335	[1]
Denominator:
Basic weighted average ordinary shares outstanding (in Shares)		17,250,000	17,250,000	[1]	17,250,000	17,075,967	[1]
Effect of dilutive securities	[1]					$ 174,033
Diluted weighted average ordinary shares outstanding (in Shares)		17,250,000	17,250,000		17,250,000	17,250,000	[1]
Basic net income per ordinary share (in Dollars per share)		$ 0.08	$ (0.11)	[1]	$ 0.29	$ 0.12	[1]
Diluted net income per ordinary share (in Dollars per share)		$ 0.08	$ (0.11)		$ 0.29	$ 0.12	[1]
[1]As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company.

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the numerator and denominator (Parentheticals) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	[1]
Class A [Member]
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the numerator and denominator (Parentheticals) [Line Items]
Allocation of net income (loss)- diluted	$ 5,247,067	$ (7,290,070)	$ 20,149,040	$ 7,884,373
Diluted weighted average ordinary shares outstanding	69,000,000	69,000,000	69,000,000	63,662,983
Diluted net income per ordinary share	$ 0.08	$ (0.11)	$ 0.29	$ 0.12
Class B [Member]
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the numerator and denominator (Parentheticals) [Line Items]
Allocation of net income (loss)- diluted	$ 1,311,767	$ (1,822,518)	$ 5,037,260	$ 2,136,335
Diluted weighted average ordinary shares outstanding	17,250,000	17,250,000	17,250,000	17,250,000
Diluted net income per ordinary share	$ 0.08	$ (0.11)	$ 0.29	$ 0.12
[1]As reported in the Company’s Form 10-Q for the Quarterly period ended September 30, 2021, the Company revised its earnings per share calculations from what was previously reported in its Quarterly Report on Form 10-Q for the Quarterly period ended June 30, 2021 to allocate income and losses shared pro rata between the two classes of shares. This revised presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares share pro rata in the income and losses of the Company.

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)		6 Months Ended
	Jan. 15, 2021	Jun. 30, 2022
Initial Public Offering (Details) [Line Items]
Deferred underwriting commissions	$ 24,200,000
Deferred legal fees	$ 213,000
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Shares issued (in Shares)	69,000,000
Price per share (in Dollars per share)	$ 10
Gross proceeds	$ 690,000,000
Offering costs	$ 38,900,000
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Shares issued (in Shares)	9,000,000
Class A Ordinary Shares [Member]
Initial Public Offering (Details) [Line Items]
Public warrant, description		Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).

Private Placement (Details)

Private Placement (Details) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares
Private Placement Warrants [Member]
Private Placement (Details) [Line Items]
Purchase of warrants (in Shares) | shares	10,533,333
Price per share	$ 1.5
Gross proceeds (in Dollars) | $	$ 15.8
Class A Ordinary Shares [Member]
Private Placement (Details) [Line Items]
Price per share	$ 11.5

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)				1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 15, 2021	Jan. 12, 2021	Oct. 15, 2020	Oct. 19, 2020	Oct. 16, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Sep. 30, 2021	Apr. 30, 2021	Jan. 08, 2021	Dec. 31, 2020	Dec. 23, 2020
Related Party Transactions (Details) [Line Items]
Principal amount					$ 300,000	$ 2,000,000		$ 2,000,000				$ 600,000
Borrowing amount														$ 181,000
Debt repaid date					Jan. 18, 2021
Working capital loans								1,600,000		$ 600,000
Borrowing amount											$ 4,000,000	$ 1,200,000
Convertible note						1,500,000		1,500,000
Working capital loans						950,000		950,000
Estimated fair value of working capital loans						1,000,000		1,000,000		592,000
General and administrative expenses to related party						30,000	$ 30,000
General and administrative expenses								60,000	$ 60,000
Consulting expenses						15,000	$ 15,000	30,000	$ 30,000
Prepaid expenses						$ 5,000		5,000		$ 5,000
Forward purchase agreement, description		the Company entered into a forward purchase agreement with QVIDTVM Management LLC (the “Forward Purchase Agreement”) providing for the purchase of up to 15,000,000 forward purchase units (the “Forward Purchase Units”), with each Forward Purchase Unit consisting of one Class A ordinary share (the “Forward Purchase Shares”) and one-third of one redeemable warrant to purchase one Class A ordinary share at $11.50 per share (the “Forward Purchase Warrants”), at a purchase price of $10.00 per Forward Purchase Unit, in a Private Placement to occur concurrently with the closing of the initial Business Combination. The number of Forward Purchase Units to be purchased by QVIDTVM Management LLC will be subject to the sole discretion of Mr. Alici, who has investment control over the capital committed to such entity, but in no event will be less than 5,000,000 Forward Purchase Units. The obligations under the Forward Purchase Agreement do not depend on whether any Class A ordinary shares held by Public Shareholders are redeemed by the Company. The obligation to purchase the Forward Purchase Units is subject to customary closing conditions, including that the initial Business Combination must be consummated substantially concurrently with, and immediately following, the purchase of Forward Purchase Units. The Forward Purchase Shares and Forward Purchase Warrants will be issued only in connection with the closing of the initial Business Combination. The proceeds from the sale of forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post-transaction company.
Warrant [Member]
Related Party Transactions (Details) [Line Items]
Working capital loans								$ 1,500,000
Price per share (in Dollars per share)						$ 1.5		$ 1.5
Initial Public Offering [Member]
Related Party Transactions (Details) [Line Items]
Public offering amount					$ 227,000
Price per share (in Dollars per share)						10		$ 10
Ordinary price per share (in Dollars per share)	$ 10
Private Placement Warrants [Member]
Related Party Transactions (Details) [Line Items]
Number of shares issued (in Shares)								10,533,333
Price per share (in Dollars per share)						1.5		$ 1.5
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)						0.0001		0.0001		$ 0.0001
Class A Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)						0.0001		0.0001		$ 0.0001
Conversion price per warrant (in Dollars per share)						1.5		1.5
Class A Ordinary Shares [Member] | Initial Public Offering [Member]
Related Party Transactions (Details) [Line Items]
Number of shares issued (in Shares)	69,000,000
Class A Ordinary Shares [Member] | Private Placement Warrants [Member]
Related Party Transactions (Details) [Line Items]
Ordinary price per share (in Dollars per share)						$ 11.5		$ 11.5
Chief Financial Officer [Member]
Related Party Transactions (Details) [Line Items]
Services amount			$ 5,000
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Aggregate shares (in Shares)				2,250,000
Percentage of issued and outstanding shares				20%
Forfeited shares (in Shares)	2,250,000
Founder Shares [Member] | Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Number of shares issued (in Shares)				14,375,000
Exchange payment				$ 25,000
Shares outstanding (in Shares)	17,250,000												17,250,000		17,250,000
Founder Shares [Member] | Business Combination [Member]
Related Party Transactions (Details) [Line Items]
Business combination, description								(i) three years after the completion of the initial Business Combination or (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least one year after the initial Business Combination, the Founder Shares will be released from the lockup.
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Office space, utilities, secretarial and administrative support services								$ 10,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Commitments and Contingencies (Details) [Line Items]
Underwriting agreement, description	The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $13.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Unit, or approximately $24.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions.
Legal fees	$ 350,000
Deferred legal fees	$ 3,800,000	$ 2,800,000
Initial Public Offering [Member]
Commitments and Contingencies (Details) [Line Items]
Purchase of additional units (in Shares)	9,000,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details) - $ / shares	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Derivative Warrant Liabilities (Details) [Line Items]
Exercise price	$ 11.5
Warrant expiration term	5 years
Redemption of warrants, description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):  ●in whole and not in part;   ●at a price of $0.10 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption;   ●if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30 trading-day period ending three trading days before the Company sends the notice of redemption to the warrant holders;   ●if the closing price of the Class A ordinary shares for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above;   ●provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares  The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted-average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).
Public Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Number of warrants outstanding	23,000,000
Private Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Number of warrants outstanding		10,533,333
Class A Ordinary Shares [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Redemption of warrants, description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):  ●in whole and not in part;   ●at a price of $0.01 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and   ●if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.  The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period.
Business Acquisition [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Business combination, description	In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities, other than the forward purchase securities, for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted-average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A Ordinary Shares [Member] - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Class A Ordinary Shares Subject to Possible Redemption (Details) [Line Items]
Common stock, shares authorized	750,000,000	750,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Shares subject to possible redemption, shares outstanding		69,000,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption (Details) - Schedule of balance sheet - Class A Ordinary Shares [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Gross proceeds from Initial Public Offering		$ 690,000,000
Less:
Proceeds allocated to public warrants		(31,280,000)
Class A ordinary shares issuance costs		(37,169,587)
Plus:
Accretion of carrying value to redemption value		68,449,587
Class A ordinary shares subject to possible redemption, December 31, 2021	$ 690,000,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	956,000
Class A ordinary shares subject to possible redemption, June 30, 2022	$ 690,956,000	$ 690,000,000

Shareholders_ Deficit (Details)

Shareholders’ Deficit (Details) - $ / shares		6 Months Ended
	Oct. 19, 2020	Jun. 30, 2022	Dec. 31, 2021	Jan. 15, 2021	Dec. 23, 2020
Shareholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value per share (in Dollars per share)		$ 0.0001	$ 0.0001
Voted on by shareholders		one
Class B Ordinary Shares [Member]
Shareholders’ Deficit (Details) [Line Items]
Common stock, shares authorized		100,000,000	100,000,000
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Common stock, shares issued		17,250,000	17,250,000
Common stock, shares outstanding		17,250,000	17,250,000	17,250,000	17,250,000
Aggregate number of shares surrender and cancel	2,250,000
Initial shareholders collectively own percentage	20%
Total number of ordinary shares outstanding, percentage		20%
Founder Shares [Member]
Shareholders’ Deficit (Details) [Line Items]
Founder Shares are no longer subject to forfeiture				2,250,000
Sponsor [Member] | Class B Ordinary Shares [Member]
Shareholders’ Deficit (Details) [Line Items]
Common stock, shares issued	14,375,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Schedule of financial assets or liabilities measured at fair value - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account – money market funds	$ 691,056,309	$ 690,076,023
Derivative assets – Forward Purchase Agreement	19,920	401,860
Liabilities:
Derivative liabilities – Public Warrants	2,990,000	20,470,000
Derivative liabilities – Private Placement Warrants	1,369,330	9,374,670
Derivative liabilities:
Total derivative liabilities:	4,359,330	30,246,530
Working Capital Loans – related party	1,042,579	592,388
Level 1 [Member]
Assets:
Investments held in Trust Account – money market funds	691,056,309	690,076,023
Derivative assets – Forward Purchase Agreement
Liabilities:
Derivative liabilities – Public Warrants	2,990,000	20,470,000
Derivative liabilities – Private Placement Warrants
Derivative liabilities:
Total derivative liabilities:	2,990,000	20,470,000
Working Capital Loans – related party
Level 2 [Member]
Assets:
Investments held in Trust Account – money market funds
Derivative assets – Forward Purchase Agreement
Liabilities:
Derivative liabilities – Public Warrants
Derivative liabilities – Private Placement Warrants	1,369,330	9,374,670
Derivative liabilities:
Total derivative liabilities:	1,369,330	9,374,670
Working Capital Loans – related party
Level 3 [Member]
Assets:
Investments held in Trust Account – money market funds
Derivative assets – Forward Purchase Agreement	19,920	401,860
Liabilities:
Derivative liabilities – Public Warrants
Derivative liabilities – Private Placement Warrants
Derivative liabilities:
Total derivative liabilities:	19,920	401,860
Working Capital Loans – related party	$ 1,042,579	$ 592,388

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of provides quantitative information Level 3 fair value	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Forward Purchase Agreement:
Expected term	6 months	6 months
Risk-free interest rate	2.48%	0.06%

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative liabilities	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of change in the fair value of the derivative liabilities [Abstract]
Derivative liabilities at December 31, 2021 - Level 3 measurement	$ 401,860
Derivative liabilities at June 30, 2022 - Level 3 measurement
Change in fair value of forward purchase agreement - Level 3 measurement	$ (401,860)

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative assets	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of change in the fair value of the derivative assets [Abstract]
Derivative assets at December 31, 2021 - Level 3 measurement
Derivative assets at June 30, 2022 - Level 3 measurement	19,920
Change in fair value of forward purchase agreement - Level 3 measurement	$ 19,920

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of fair value measurement of working capital loan - Working capital loan [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Exercise price (in Dollars per share)	$ 1.5	$ 1.5
Volatility	44.50%	68.20%
Expected term	6 months	6 months
Risk-free interest rate	2.48%	0.19%
Probability of Business Combination	70%	100%

Fair Value Measurements (Deta_6

Fair Value Measurements (Details) - Schedule of change in the fair value of the working capital loan	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of change in the fair value of the working capital loan [Abstract]
Working capital loan – related party at December 31, 2021 - Level 3 measurement	$ 592,388
Working capital loan – related party at June 30, 2022 - Level 3 measurement	1,042,579
Proceeds from working capital loan to related party	950,025
Change in fair value of working capital loan - Level 3 measurement	$ (499,834)